Joel Pieper
Physical Medicine & Rehabilitation · Raleigh, NCNPI 1841722121
Payments from drug & device makers
Across 14 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$149
- Otsuka America Pharmaceutical, Inc.$42
- Neurelis, Inc.$25
- Collegium Pharmaceutical, Inc.$21
- Ipsen Biopharmaceuticals, Inc$19
What the payments were for
- Food & beverage$255100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $149 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Neurelis, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
How this compares
$255 in reported general payments places this provider in the 45th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
See all physical medicine & rehabilitation providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 220 | $54,661 |
| XareltoRivaroxaban | 93 | $28,181 |
| MounjaroTirzepatide | 33 | $11,499 |
| JanuviaSitagliptin Phosphate | 28 | $7,999 |
| TrulicityDulaglutide | 16 | $7,524 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 20 | $6,221 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $5,819 |
| Spiriva RespimatTiotropium Bromide | 35 | $3,881 |
| Atorvastatin Calcium | 181 | $3,399 |
| TradjentaLinagliptin | 15 | $3,183 |
| Advair DiskusFluticasone Propion/Salmeterol | 12 | $2,766 |
| Amlodipine Besylate | 164 | $2,547 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $2,520 |
| Levothyroxine Sodium | 135 | $2,383 |
| Sertraline Hcl | 113 | $2,320 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Raleigh
- Patrick O BrienRaleigh$86K
- Emmanuel SaklaRaleigh$9K
- Mark ReznikRaleigh$6K
- Derek WatsonRaleigh$2K
- William BockenekCharlotte$446K
- Andrew SumichCharlotte$181K
- Jeremy HoffWilmington$152K
- William BeckworthHendersonville$104K
- Michael OrtizCharlotte$62K
- Elizabeth BagsbyGreenville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.